Opens in a new tab
Monday, 16 November 2026
EVIDENCE. INTERPRETED.
Disease & Drugs

Research

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Advertisement · Remove ads
970 × 90

Latest in Research

139 stories · every one Fact-Checked
Study finds intensive hydration programme increased urine volume but did not reduce recurrent kidney stonesResearchDoes Drinking More Water Really Prevent Kidney Stones? Large Trial Challenges a Common AssumptionA large Lancet trial found that an intensive programme to increase fluid intake raised urine volume but did not reduce symptomatic kidney stone recurrence over two years.7 Sep 2026 · 4 min read
Fact-Checked
Older adult discussing statin treatment with a healthcare professionalResearchStopping Statins After 75: What a New Randomized Trial FoundA randomized SAGA/SITE trial suggests that some adults aged 75 and older taking statins for primary prevention may be able to discontinue treatment without increasing three-year mortality, although…27 Aug 2026 · 4 min read
Fact-Checked
NRG5051 NLRX1-mediated mPTP mechanism for ALSResearchNRG5051 Targets mPTP Through Novel NLRX1 Mechanism in ALSNRG Therapeutics has disclosed a novel NLRX1-mediated mechanism through which NRG5051 inhibits the mitochondrial permeability transition pore (mPTP), alongside preclinical data showing anti-inflammatory and neuroprotective effects in ALS…25 Aug 2026 · 3 min read
Fact-Checked
Organoids used in drug development and human-based biomedical researchResearchOrganoids Are Reshaping Drug Development as Research Moves from Animal Studies to Human-Based ModelsA JAMA analysis explores how organoids are emerging as human-based models for disease research, drug discovery, personalized medicine and clinical development, while researchers address challenges in standardization and…22 Aug 2026 · 5 min read
Fact-Checked
Conceptual illustration of gene and cell therapy safety, AAV vector toxicity, clinical trial oversight and post-marketing pharmacovigilanceResearchSafety of Experimental Gene and Cell Therapies Under Scrutiny: What Recent Trial Fatalities and Post-Marketing Experience Tell UsRecent fatalities in experimental gene and cell therapy trials in China have renewed questions about investigator-initiated trial oversight.22 Aug 2026 · 14 min read
Fact-Checked
Five-year FIREFISH results of risdiplam in children with type 1 spinal muscular atrophyResearchCan Risdiplam Sustain Survival and Motor Function in Children with Type 1 SMA Over 5 Years?Five-year FIREFISH results show that 90% of children with type 1 SMA remained alive and 80% were alive without permanent ventilation after long-term risdiplam treatment, with sustained motor…19 Aug 2026 · 4 min read
Fact-Checked
Dexamethasone eye drops with retinal blood vessels and premature infant representing retinopathy of prematurity researchResearchCan Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurity?The DROPROP randomized clinical trial found a numerical reduction in treatment-requiring retinopathy of prematurity with topical dexamethasone in preterm infants, highlighting a potential new application for a long-established…18 Aug 2026 · 4 min read
Fact-Checked
Long-acting HIV antibodies 3BNC117-LS and 10-1074-LS delay viral rebound in the Phase 2 RIO trialResearchLong-Acting Broadly Neutralising Antibodies Delay HIV Viral Rebound After ART InterruptionThe Phase 2 RIO trial found that the long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS substantially delayed HIV viral rebound after antiretroviral therapy interruption.15 Aug 2026 · 3 min read
Fact-Checked
Penn Medicine researchers found CD19 CAR T cells can persist for up to a decade in B-cell lymphoma, revealing long-term cellular and clonal changes.ResearchAfter 10-Year Clinical Outcomes, Penn Medicine Study Finds CD19 CAR T Cells Persist for a Decade in B-Cell LymphomaPenn Medicine researchers found long-term persistence of CD19 CAR T cells in a subset of lymphoma patients, with detailed analyses…12 Aug 2026 · 4 min read
Fact-Checked
NDRG1-linked DNA repair vulnerability in colorectal cancer cellsResearchInsilico Medicine Identifies NDRG1 as a New DNA Repair Target in Colorectal CancerResearchers identified NDRG1 as a regulator of the DNA damage response and found that colorectal cancer cells with specific DNA repair alterations may be vulnerable to NDRG1-directed strategies…10 Aug 2026 · 4 min read
Fact-Checked
The Phase 3 SOLARIS trial found high-dose vitamin D3 did not improve progression-free survival versus standard-dose vitamin D3 in metastatic colorectal cancer.ResearchHigh-Dose Vitamin D3 Does Not Improve Progression-Free Survival in Metastatic Colorectal Cancer in Phase 3 SOLARIS TrialThe Phase 3 SOLARIS trial found that adding high-dose vitamin D3 to standard chemotherapy and bevacizumab did not significantly improve progression-free survival in previously untreated metastatic colorectal cancer.…8 Aug 2026 · 3 min read
Fact-Checked
Illustration representing dronabinol (BX-1) reducing PTSD-related nightmares in a randomized placebo-controlled clinical trial published in Nature Medicine.ResearchNew Nature Study Finds Dronabinol Reduced Trauma-Related NightmaresA Phase II randomized controlled trial published in Nature Medicine found that oral dronabinol significantly reduced the frequency and intensity of PTSD-related nightmares compared with placebo.7 Aug 2026 · 4 min read
Fact-Checked
Page 1 of 12